These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4691232)

  • 1. A new anti-erythrocyte antibody in the Duffy system: anti-Fy4.
    Behzad O; Lee CL; Gavin J; Marsh WL
    Vox Sang; 1973 Apr; 24(4):337-42. PubMed ID: 4691232
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of anti-Fya in five black Fy(a-b-) patients.
    Le Pennec PY; Rouger P; Klein MT; Robert N; Salmon C
    Vox Sang; 1987; 52(3):246-9. PubMed ID: 3604183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present status of the Duffy blood group system.
    Marsh WL
    CRC Crit Rev Clin Lab Sci; 1975 Mar; 5(4):387-412. PubMed ID: 49254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three examples of anti-Fy3 produced in Negroes.
    Kosinski KS; Molthan L; White L
    Rev Fr Transfus Immunohematol; 1984 Oct; 27(5):619-24. PubMed ID: 6522936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automation in the blood transfusion laboratory: I. Antibody dectection and quantitation in the technicon autoanalyzer.
    Moore BP
    Can Med Assoc J; 1969 Feb; 100(8):381-7. PubMed ID: 4974689
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new antibody, anti-K12, associated with the Kell blood group system.
    Marsh WL; Stroup M; Macilroy M; Oyen R; Reid ME; Heisto H
    Vox Sang; 1973 Mar; 24(3):200-5. PubMed ID: 4570321
    [No Abstract]   [Full Text] [Related]  

  • 11. A second example of anti-Fy3 in the Duffy blood group system.
    Oberdorfer CE; Kahn B; Moore V; Zelenski K; Oyen R; Marsh WL
    Transfusion; 1974; 14(6):608-11. PubMed ID: 4610917
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed haemolytic transfusion reaction due to simultaneous appearance of anti-Fya and Anti-Fy5.
    Bowen DT; Devenish A; Dalton J; Hewitt PE
    Vox Sang; 1988; 55(1):35-6. PubMed ID: 3420847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A papain-bromelin-polybrene four-channel autoanalyzer system for blood group antibody screening. Analysis of 22,912 sera.
    Habibi B; Gerbal A; Salmon C
    Vox Sang; 1973 Oct; 25(4):289-97. PubMed ID: 4752603
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Au: the antithetical antibody to anti-Au.
    Frandson S; Atkins CJ; Moulds M; Poole J; Crawford MN; Tippett P
    Vox Sang; 1989; 56(1):54-6. PubMed ID: 2644738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.
    Ambruso DR; Githens JH; Alcorn R; Dixon DJ; Brown LJ; Vaughn WM; Hays T
    Transfusion; 1987; 27(1):94-8. PubMed ID: 3810834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 17. For the patient. Alloimmunization: one risk of treating sickle cell disease.
    Ethn Dis; 2010; 20(2):195. PubMed ID: 20506598
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
    Vichinsky EP; Luban NL; Wright E; Olivieri N; Driscoll C; Pegelow CH; Adams RJ;
    Transfusion; 2001 Sep; 41(9):1086-92. PubMed ID: 11552063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of blood groups in transfusion of sickle cell disease patients.
    Noizat-Pirenne F
    C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia.
    Sarnaik S; Schornack J; Lusher JM
    Transfusion; 1986; 26(3):249-52. PubMed ID: 3705143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.